Industry News
Parkway Properties Forms $750M Discretionary Fund with Teacher Retirement System
May 16, 2008

Parkway Properties Inc.  has signed limited partnership agreement forming Parkway Properties Office Fund II L.P.,  a $750 million discretionary fund with the Teacher Retirement System of Texas, for the purpose of acquiring high-quality multi-tenant office properties. TRS will be a 70 percent investor, and Parkway will be a 30 percent investor in the fund, which will be capitalized with approximately $375 million of equity capital and $375 million of non-recourse, fixed-rate first mortgage debt. Fund II will target investments in office buildings in Houston, Austin, San Antonio, Chicago, Atlanta, Phoenix, Charlotte, Memphis, Nashville, Jacksonville, Orlando, Tampa/St. Petersburg, Ft. Lauderdale, as well as other growth markets to be determined at Parkway's discretion.

 
Recent Industry News Headlines
Corus Bank Completes $60M Loan to Finance MF Construction in Washington, D.C.
Corus Bankshares Inc. said that its banking subsidiary, Corus Bank, closed a $60 million loan to a joint venture between The Cohen Cos. and O’Connor Capital Partners L.L.C. to finance the construction of Velocity, a 14-story condominium building located at 1025 First Street SE in Washington, D.C.
Carlton Arranges $630M Equity, Debt Recapitalization of Manhattan Retail Complex
Carlton Advisory Services announce the $630 million equity and debt recapitalization of the retail condominium at 666 Fifth Avenue in New York City.
Hines Sets New Public Offering
Hines Real Estate Investment Trust Inc. has announced today that its third public offering was declared effective by the Securities and Exchange Commission on July 1, 2008.
7CI Unveils Raffles Resort, Praslin Island at Raffles Dubai
7CI, the global investment specialist, is unveiling Raffles Estates on Praslin Island, Seychelles in Raffles Dubai. The Raffles Estate, Seychelles is located on the northeast tip of Praslin Island.
Pharmaceutical Firm Leases 40,000SF at 600-Acre Business Park
KaloBios Pharmaceutical has snagged 40,000 square feet at 260 East Grand Avenue in South San Francisco, Calif. for its new headquarters location.